Want to see SE:SERT full AI Analyst Report?
Serstech AB (SERT) AI Stock Analysis
Serstech AB
(Nasdaq OMX AB:SERT)
The score is primarily held down by weak financial performance—large ongoing losses and significant negative operating/free cash flow—despite some balance-sheet buffer and TTM revenue growth. Technicals are largely neutral with slightly negative momentum, and valuation provides limited support because earnings are negative and no dividend yield is available.
Serstech AB (SERT) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 123.09M
- Dividend Yield
- ―
- Average Volume (3M)
- 152.86K
- Price to Earnings (P/E)
- -4.3
- Beta (1Y)
- 0.41
- Revenue Growth
- -26.35%
- EPS Growth
- -5.95%
- Country
- Sweden
- Employees
- 26
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Serstech AB Business Overview & Revenue Model
Company Description
Founded in 2006 and headquartered in Lund, Sweden, Serstech AB is a global provider of advanced chemical identification instruments. The company's offerings include the compact, lightweight, handheld Serstech 100 Indicator, a Raman spectrometer capab...
How the Company Makes Money
Serstech AB primarily makes money by selling its chemical identification products (portable/handheld analyzers) and associated software used to detect and identify substances in operational environments. Revenue is generated from (1) product sales of...
Serstech AB Financial Statement Overview
Summary
Financial performance is weak: despite TTM revenue growth (+20.2%) and gross profit turning positive again, profitability has deteriorated sharply with very large losses (TTM net margin about -137%). Cash flow is a major risk with deeply negative operating cash flow (-24.8m) and free cash flow (-29.1m). The balance sheet provides some buffer (moderate leverage; 10.0m debt vs 36.0m equity), but returns remain strongly negative (ROE about -65%), indicating ongoing value erosion if losses persist.
Income Statement
22NegativeBalance Sheet
44NeutralCash Flow
18Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.31M | 38.59M | 52.26M | 62.76M | 25.89M | 18.65M |
| Gross Profit | 25.05M | -20.80M | 38.33M | 48.44M | 21.71M | 15.53M |
| EBITDA | -19.35M | -20.59M | -8.78M | 12.98M | -22.21M | -3.26M |
| Net Income | -28.96M | -29.27M | -9.13M | 715.00K | -29.57M | -10.25M |
Balance Sheet | ||||||
| Total Assets | 58.33M | 57.49M | 94.72M | 59.71M | 52.55M | 66.56M |
| Cash, Cash Equivalents and Short-Term Investments | 4.17M | 9.76M | 9.29M | 18.47M | 1.87M | 19.57M |
| Total Debt | 10.00M | 0 | 0 | 1.80M | 4.74M | 1.70M |
| Total Liabilities | 22.31M | 9.71M | 18.16M | 11.74M | 25.93M | 10.45M |
| Stockholders Equity | 36.02M | 47.79M | 76.56M | 47.97M | 26.62M | 56.11M |
Cash Flow | ||||||
| Free Cash Flow | -34.09M | -37.41M | -8.49M | -1.37M | -20.75M | -13.19M |
| Operating Cash Flow | -24.79M | -28.02M | 562.00K | 7.63M | -13.16M | -628.00K |
| Investing Cash Flow | -9.30M | -9.40M | -7.95M | -9.00M | -7.59M | -12.55M |
| Financing Cash Flow | 10.29M | 37.88M | -1.80M | 17.98M | 3.04M | 21.36M |
Serstech AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SERT, the sentiment is Negative. The current price of 0.48 is below the 20-day moving average (MA) of 0.51, below the 50-day MA of 0.52, and below the 200-day MA of 0.49, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 41.96 is Neutral, neither overbought nor oversold. The STOCH value of 25.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:SERT.
Serstech AB Peers Comparison
Overall Rating
SE:ARPL72Outperform
SE:ORGC45Neutral
SE:POLYG44Neutral
SE:NEXAM43Neutral
SE:SERT43Neutral
SE:AXIC.A38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | SEK 805.63M | 11.03 | 10.54% | 4.17% | -13.36% | -31.32% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 45Neutral | SEK 83.91M | -1.52 | -176.65% | ― | -21.95% | -28.77% | |
| 44Neutral | SEK 85.47M | -19.61 | -1.52% | ― | -18.26% | 35.77% | |
| 43Neutral | SEK 258.28M | -12.35 | -9.37% | ― | -4.57% | -15.20% | |
| 43Neutral | SEK 123.09M | -4.31 | -63.36% | ― | -26.35% | -5.95% | |
| 38Underperform | SEK 133.98M | -7.04 | -27.51% | ― | 36.35% | 38.34% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:SERT | Serstech AB | 0.48 | -0.03 | -6.38% | |
| SE:NEXAM | Nexam Chemical Holding AB | 2.52 | -0.60 | -19.23% | |
| SE:POLYG | Polygiene AB | 2.34 | -7.06 | -75.11% | |
| SE:AXIC.A | aXichem AB Class A | 1.75 | -0.97 | -35.48% | |
| SE:ORGC | OrganoClick AB | 0.46 | -1.42 | -75.64% | |
| SE:ARPL | Arla Plast AB | 38.40 | -20.72 | -35.04% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 19, 2026